Prospera Financial Services Inc
Position in NBIX — Neurocrine Biosciences Inc
CIK 1541625
Dallas, TX
Position in NBIX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$240,843
-$311,584 QoQ
Shares Held
1,429
-63.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#569
of 768 holders
Holding Since
Sep 2020
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Prospera Financial Services Inc holds $7,295,158 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (3.3% of the industry book) .
All Filings in NBIX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $240,843 | 1,429 | Shares | Sole | 2026-07-15 | |
| 2025-12-31 | $552,427 | 3,895 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $540,884 | 3,853 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $482,021 | 3,835 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $296,076 | 2,677 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $353,671 | 2,591 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $297,498 | 2,582 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $358,768 | 2,606 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $405,346 | 2,939 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $374,066 | 2,839 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $328,950 | 2,924 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $282,617 | 2,997 | Shares | Sole | 2023-08-08 | |
| 2022-03-31 | $46,500 | 496 | Shares | Sole | 2022-05-04 | |
| 2020-09-30 | $961 | 10 | Shares | Sole | 2020-11-04 | |
| No filing history on record for this holder in this stock. | ||||||